Clinical Parameters Affecting the Therapeutic Efficacy of SGLT-2—Comparative Effectiveness and Safety of Dapagliflozin and Empagliflozin in Patients with Type 2 Diabetes

(1) Background. We aimed to assess long-term efficacy and safety in inadequately controlled type 2 diabetes (T2DM) of two SGLT-2 inhibitors: empagliflozin (Empa) and dapagliflozin (Dapa), combined with metformin, other oral antidiabetics or insulin, according to the protocols in Romania. (2) Methods...

Descripción completa

Detalles Bibliográficos
Autores principales: Anton, Irina Claudia, Mititelu-Tartau, Liliana, Popa, Eliza Gratiela, Poroch, Mihaela, Poroch, Vladimir, Pintilei, Delia Reurean, Botnariu, Gina Eosefina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316348/
https://www.ncbi.nlm.nih.gov/pubmed/35885680
http://dx.doi.org/10.3390/healthcare10071153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316348/
https://www.ncbi.nlm.nih.gov/pubmed/35885680
http://dx.doi.org/10.3390/healthcare10071153

Ejemplares similares